NOZZOLILLO, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 89
EU - Europa 33
AS - Asia 29
AF - Africa 7
Totale 158
Nazione #
US - Stati Uniti d'America 89
IT - Italia 21
SG - Singapore 20
CI - Costa d'Avorio 7
NL - Olanda 4
VN - Vietnam 4
DE - Germania 3
GB - Regno Unito 3
IN - India 3
CN - Cina 2
BE - Belgio 1
FI - Finlandia 1
Totale 158
Città #
Singapore 17
Chandler 10
Ashburn 8
Santa Clara 7
Lawrence 5
Millbury 5
Naples 5
Amsterdam 4
Boston 4
Des Moines 4
Dong Ket 4
Afragola 2
Dallas 2
Grottaferrata 2
Redhill 2
Rome 2
Wilmington 2
Beijing 1
Brussels 1
Catania 1
Fairfield 1
Frankfurt am Main 1
Fremont 1
Lappeenranta 1
Los Angeles 1
Munich 1
Napoli 1
Pune 1
San Sebastiano Al Vesuvio 1
Torre del Greco 1
Totale 98
Nome #
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 34
Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience 26
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 24
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis 24
Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study) 23
Signs and symptoms of COVID-19 in patients with multiple sclerosis 20
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials 13
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 7
Totale 171
Categoria #
all - tutte 1.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 4 1 1
2020/20218 0 0 0 3 1 0 0 0 0 0 0 4
2021/202235 1 0 0 3 0 2 0 1 1 7 7 13
2022/202342 5 2 1 0 3 7 1 4 10 6 3 0
2023/202446 1 9 1 1 2 6 4 7 0 2 6 7
2024/202534 8 13 1 3 9 0 0 0 0 0 0 0
Totale 171